United Kingdom (UK) Respiratory Care Devices Market Overview, 2031

The respiratory devices sector in the UK has progressed closely with improvements in lung care, largely influenced by the National Health Service NHS. Initially, these devices were introduced and standardized in public hospitals to aid in emergency care, anesthesia, and urgent respiratory treatment. Over the years, the industry broadened to encompass inhalers, nebulizers, and non-invasive ventilation devices, especially for treating asthma and various chronic respiratory diseases that are still widespread in the UK. Essentially, respiratory devices are made to aid breathing, deliver medications directly to the lungs, or monitor breathing functions, proving essential for both immediate and long-term management of illnesses. Their success is evident in better symptom control, fewer hospital visits, and improved patient well-being, particularly in asthma management where inhalation therapy is key to treatment approaches. The UK market has increasingly profited from research and development backed by robust partnerships between academia and industry, taking advantage of the nation’s established life sciences industry and clinical research capabilities. Academic institutions, NHS organizations, and medical device producers work together to create innovative, patient-focused respiratory solutions, such as digital inhalers and remote monitoring devices. Oversight of regulations is managed by the Medicines and Healthcare products Regulatory Agency MHRA, with adherence to UK Conformity Assessed UKCA marking ensuring that devices are safe, effective, and high-quality following the UK's regulatory changes. These compliance measures address device reliability and patient safety risks, while fostering ongoing innovation and market trust.

According to the research report, " UK Respiratory Devices Market Overview, 2031," published by Bonafide Research, the UK Respiratory Devices market is anticipated to grow at more than 6.53% CAGR from 2026 to 2031. The value of the UK's respiratory devices market is in the multi-billion-dollar range and is projected to grow steadily at a consistent CAGR during the forecast period, driven by ongoing demand for managing chronic respiratory illnesses and advances in technology. Recent trends in the market show a rise in the use of at-home respiratory care devices, like portable oxygen concentrators, CPAP machines, and connected inhalers, mirroring the NHS’s strategic goal to lower inpatient care expenses. Leading suppliers in the UK market include Philips, ResMed, Medtronic, alongside several local manufacturers that offer a wide variety of therapeutic, diagnostic, and monitoring respiratory products. These companies persist in investing in digital health integration, making devices smaller, and creating user-friendly designs to fit NHS care practices. Market possibilities are closely tied to NHS strategies for cost reduction, which emphasize early diagnosis, outpatient care, and home treatment models to lessen hospital strain. Moreover, the UK’s aging population and high rates of asthma and COPD further bolster sustainable market growth. The growth of remote patient monitoring and community-focused respiratory care services provides significant chances for manufacturers to deliver effective, compliant, and scalable respiratory products tailored to the requirements of the UK healthcare system.

UK Respiratory Devices market by product type is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. The segmentation of the UK respiratory devices market based on product type underscores the nation's commitment to clinically validated and cost-efficient solutions implemented through the National Health Service NHS. Therapeutic devices take the lead in the market, propelled by the extensive application of inhalers, nebulizers, ventilators, and CPAP/BiPAP units for managing both acute and chronic respiratory issues. Inhalation therapy is key to treatment strategies in the UK, especially for asthma and COPD, resulting in a consistent need for metered-dose and dry-powder inhalers. Monitoring devices are becoming increasingly significant as the NHS embraces remote and community-focused care models. Equipment like pulse oximeters, capnography devices, and connected respiratory monitors aid in early intervention, follow-ups after discharge, and ongoing disease management. The use of diagnostic devices, such as spirometers and pulmonary function testing equipment, is commonplace in primary care settings, respiratory clinics, and community health environments to facilitate early detection and minimize delays in specialist referrals. Recent advancements in digital spirometry alongside electronic health records have enhanced operational efficiency. Consumables and accessories, including masks, tubing, breathing circuits, filters, and components for inhalers, form a stable and recurring market segment due to rigorous infection control standards within NHS facilities. UKCA certification and MHRA scrutiny impact purchasing choices, promoting the use of high-quality, compliant products. The landscape of product types in the UK is marked by strong demand for therapeutic and consumable devices, complemented by an increasing uptake of monitoring and diagnostic technologies in line with NHS efficiency objectives.

UK Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. The segmentation of end users in the UK respiratory devices market showcases the nation's unified care framework and the ongoing trend towards more decentralized healthcare services. Hospitals continue to be the primary users, with a large need for ventilators, diagnostic equipment, and devices for respiratory monitoring, especially in emergency and intensive care environments. NHS hospitals play a critical role as places for advanced respiratory therapies and research activities. Ambulatory Care Centers ACCs and community clinics are becoming increasingly significant as the NHS broadens its outpatient and same-day treatment offerings. These facilities make use of portable diagnostic equipment, spirometers, and non-invasive devices to effectively manage long-term illnesses and minimize hospital stays. Home care settings have emerged as one of the quickest growing segments of end users, influenced by NHS plans to oversee chronic conditions outside hospital settings. Devices for home oxygen therapy, machines for sleep apnea, and tools for remote monitoring are commonly used to enhance patient autonomy and lower care expenses. Other end users, such as rehabilitation facilities, long-term care institutions, and hospices, also play a part in consistent demand for reliable and user-friendly respiratory devices. The UK's emphasis on integrated care systems ICSs and community-driven services is continually altering end-user requirements, highlighting the increasing significance of homecare and outpatient respiratory options.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"